Fidelity Investments’s Eton Pharmaceutcials ETON Stock Holding History

Fidelity Investments’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.9K	Buy	2,125 +606	+40%	+$17.8K	﹤0.01%	4104
2026 Q1	$37.5K	Sell	1,519 -1,557	-51%	-$27.2K	﹤0.01%	4250
2025 Q4	$52K	Sell	3,076 -2,618	-46%	-$46.1K	﹤0.01%	4093
2025 Q3	$124K	Buy	5,694 +5,239	+1,151%	+$86.9K	﹤0.01%	3576
2025 Q2	$6.48K	Buy	455 +445	+4,450%	+$7.04K	﹤0.01%	4647
2025 Q1	$130	Buy	+10	New	+$151	﹤0.01%	5111
2023 Q1	–	Sell	-900	Closed	-$2.52K	–	5357
2022 Q4	$2.52K	Buy	+900	New	+$2.42K	﹤0.01%	4452

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Fidelity Investments's ETON Position: Q2 2026 in Review

Fidelity Investments increased its Eton Pharmaceutcials (ETON) stake by 40% in Q2 2026, buying an estimated $17.8K and bringing the position to 2,125 shares worth $76.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4104.

Fidelity Investments first reported a position in ETON in Q4 2022 and has held it in 7 quarters since. The position peaked at $124K in Q3 2025. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

Fidelity Investments held 2,125 shares of Eton Pharmaceutcials worth $76.9K as of Q2 2026.
Fidelity Investments bought 606 Eton Pharmaceutcials shares in Q2 2026, an estimated $17.8K.
Eton Pharmaceutcials made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4104 holding.
Fidelity Investments first reported a position in Eton Pharmaceutcials in Q4 2022 and has held it in 7 quarters since.
Fidelity Investments's Eton Pharmaceutcials position peaked at $124K in Q3 2025.
164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.